14 March 2018
David Smith, Mayo Clinic, Rochester
It’s all very well to talk excitedly of genome sequencing and targeted therapies, but who gets access to this technology, particularly if it comes with a high price tag? One of the speakers at the Festival of Genomics, Professor David Smith from the Mayo Clinic in Rochester, Minnesota, raised the issue of democratising genomics - making sure that everyone gets fair access to this potentially life-changing new area of medicine. So, asks Kat Arney, what does this look like, and are we there yet?
Add a comment